Skip to main content
. 2023 Apr 11;10(3):2010–2018. doi: 10.1002/ehf2.14347

Figure 3.

Figure 3

Risk of end stage renal disease and all‐cause mortality in heart failure with preserved ejection fraction patients prescribed SGLT2i after adjusting for age, sex, race, hypertension status, and diabetes status. Kaplan–Meier curves for mortality were also adjusted for chronic kidney disease status.